UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury

Kolatsi-Joannou, M; Price, KL; Winyard, PJ; Long, DA; (2011) Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury. PLOS ONE , 6 (4) , Article e18683. 10.1371/journal.pone.0018683. Green open access

[thumbnail of 1304597.pdf]
Preview
PDF
1304597.pdf

Download (2MB)

Abstract

Galectin-3 is a beta-galactoside binding lectin with roles in diverse processes including proliferation, apoptosis, inflammation and fibrosis which are dependent on different domains of the molecule and subcellular distribution. Although galectin-3 is known to be upregulated in acute kidney injury, the relative importance of its different domains and functions are poorly understood in the underlying pathogenesis. Therefore we experimentally modulated galectin-3 in folic acid (FA)-induced acute kidney injury utilising modified citrus pectin (MCP), a derivative of pectin which can bind to the galectin-3 carbohydrate recognition domain thereby predominantly antagonising functions linked to this role. Mice were pre-treated with normal or 1% MCP-supplemented drinking water one week before FA injection. During the initial injury phase, all FA-treated mice lost weight whilst their kidneys enlarged secondary to the renal insult; these gross changes were significantly lessened in the MCP group but this was not associated with significant changes in galectin-3 expression. At a histological level, MCP clearly reduced renal cell proliferation but did not affect apoptosis. Later, during the recovery phase at two weeks, MCP-treated mice demonstrated reduced galectin-3 in association with decreased renal fibrosis, macrophages, proinflammatory cytokine expression and apoptosis. Other renal galectins, galectin-1 and -9, were unchanged. Our data indicates that MCP is protective in experimental nephropathy with modulation of early proliferation and later galectin-3 expression, apoptosis and fibrosis. This raises the possibility that MCP may be a novel strategy to reduce renal injury in the long term, perhaps via carbohydrate binding-related functions of galectin-3.

Type: Article
Title: Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
Open access status: An open access version is available from UCL Discovery
DOI: 10.1371/journal.pone.0018683
Publisher version: http://dx.doi.org/10.1371/journal.pone.0018683
Language: English
Additional information: © 2011 Kolatsi-Joannou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This work was funded by Kidney Research UK (project grant to PJW and DAL (RP33/2008) and a Senior Non-Clinical Fellowship (to DAL, SF1/2008)) and Kids Kidney Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Keywords: ACUTE-RENAL-FAILURE, PROSTATE-CANCER CELLS, FOLIC-ACID, GROWTH-FACTOR, MOUSE KIDNEY, RAT, APOPTOSIS, INHIBITION, FIBROSIS, PROLIFERATION
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept
URI: https://discovery.ucl.ac.uk/id/eprint/1304597
Downloads since deposit
173Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item